Merck’s heart failure drug misses trial goals |  |
|
Posted by Mary Canady June 5th, 2009 .
| |
| No Comments |
Merck says its heart failure treatment rolofylline missed its goals in a trial, failing to improve patient symptoms compared with a placebo.
See other entries categorized in News, San Diego Union Tribune, Syndication.
Print This Post
.
Subscribe by RSS or email. Connect with San Diego Biotech professionals by joining the SDBN and attending our next event.
Print This Post
.
Subscribe by RSS or email. Connect with San Diego Biotech professionals by joining the SDBN and attending our next event.
